Verition Fund Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.21M Buy
+8,711
New +$2.31M 0.02% 728
2026
Q1
Sell
-59,040
Closed -$9.82M 3702
2025
Q4
$9.82M Sell
59,040
-10,911
-16% -$1.83M 0.04% 471
2025
Q3
$13.7M Buy
69,951
+16,679
+31% +$2.74M 0.06% 352
2025
Q2
$4.82M Sell
53,272
-33,319
-38% -$2.63M 0.02% 1151
2025
Q1
$5.17M Buy
86,591
+73,952
+585% +$6.84M 0.02% 807
2024
Q4
$1.67M Sell
12,639
-16,452
-57% -$1.54M 0.01% 1676
2024
Q3
$1.52M Buy
+29,091
New +$1.37M 0.01% 1595

Other funds holding ALAB

Verition Fund Management's ALAB Position: Q2 2026 in Review

Verition Fund Management opened a new position in Astera Labs (ALAB) in Q2 2026: 8,711 shares worth $4.21M. The stake represents 0.02% of the portfolio and ranks #728 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in ALAB as recently as Q4 2025.

Verition Fund Management first reported a position in ALAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $13.7M in Q3 2025. 982 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Verition Fund Management held 8,711 shares of Astera Labs worth $4.21M as of Q2 2026.
  • Astera Labs was a new Verition Fund Management position in Q2 2026.
  • Astera Labs made up 0.02% of Verition Fund Management's portfolio in Q2 2026, its #728 holding.
  • Verition Fund Management first reported a position in Astera Labs in Q3 2024 and has held it in 7 quarters since.
  • Verition Fund Management's Astera Labs position peaked at $13.7M in Q3 2025.
  • 982 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.